Inventor · disambiguated record
Jinhwa Lee
Also filed as: LEE JINHWA
29 granted patents·8 pending applications·88 citations·filing 2002–2023
94Inventor score
Files with1ST BIOTHERAPEUTICS INC13LEE JINHWA10GREEN CROSS CORP5SMITHKLINE BEECHAM CORP5CHO YOUNG LAG1
Top patents by PatentIndex Score
37 records- 0194US8586550B2Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising sameLEE JINHWA·Filed 2011·Granted Nov 19, 2013·26 cites·10 claims
- 0287US10385046B1Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2019·Granted Aug 20, 2019·4 cites·14 claims
- 0387US9029389B2Anti-inflammation compoundsNO ZAESUNG·Filed 2012·Granted May 12, 2015·27 cites·13 claims
- 0485US11802126B2Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2021·Granted Oct 31, 2023·1 cites·23 claims
- 0585US10669246B2Benzothiazol compounds and methods using the same for treating neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2018·Granted Jun 2, 2020·5 cites·20 claims
- 0679US11098044B2Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·1 cites·24 claims
- 0778US6797730B2Peptide deformylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Sep 28, 2004·8 cites·4 claims
- 0875US10968188B2Benzothiazol compounds and methods using the same for treating neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2020·Granted Apr 6, 2021·1 cites·20 claims
- 0974US8541380B2C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising sameLEE JINHWA·Filed 2010·Granted Sep 24, 2013·3 cites·16 claims
- 1071US8178551B2Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatmentLEE JINHWA·Filed 2008·Granted May 15, 2012·1 cites·7 claims
- 1170US7019003B2Peptide deformylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Mar 28, 2006·6 cites·10 claims
- 1267US8754210B2Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl) derivative and intermediate used thereinCHO YOUNG LAG·Filed 2010·Granted Jun 17, 2014·1 cites·6 claims
- 1366US8835436B2Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising sameLEE JINHWA·Filed 2010·Granted Sep 16, 2014·1 cites·3 claims
- 1465US12509458B2[18F]-labeled imidazopyridine derivatives as PET radiotracer1ST BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 30, 2025·0 cites·11 claims
- 1563US7442793B2Peptide deformylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Oct 28, 2008·2 cites·5 claims
- 1661US7919528B2Peptide deformylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2003·Granted Apr 5, 2011·1 cites·44 claims
- 1759US11649255B2Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same1ST BIOTHERAPEUTICS INC·Filed 2021·Granted May 16, 2023·0 cites·19 claims
- 1858US11834467B2Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors1ST BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 5, 2023·0 cites·24 claims
- 1957US2025197406A1Indazoles as hematopoietic progenitor kinase 1 (hpk1) inhibitors and methods for using same1ST BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2055US8895558B2Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disordersLEE JINHWA·Filed 2009·Granted Nov 25, 2014·0 cites·3 claims
- 2153US8309584B2Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonistsLEE JINHWA·Filed 2008·Granted Nov 13, 2012·0 cites·7 claims
- 2252US12398156B2Compounds for prevention or treatment of neurodegenerative disorders1ST BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 26, 2025·0 cites·14 claims
- 2351US11744824B22-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds1ST BIOTHERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·22 claims
- 2451US2008207705A1Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor AntagonistsGREEN CROSS CORP·Filed 2008·Application pending·0 cites
- 2550US2022160902A1[18F]-Labeled Benzothiazole Derivative As PET Radiotracer1ST BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2649US2008262066A1Azole Derivatives as Cannabinoid CB1 Receptor AntagonistsGREEN CROSS CORP·Filed 2008·Application pending·0 cites
- 2748US2008207704A1Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonistsGREEN CROSS CORP·Filed 2007·Application pending·0 cites
- 2846US7875647B2Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonistsGREEN CROSS CORP·Filed 2007·Granted Jan 25, 2011·0 cites·6 claims
- 2946US2008081815A1Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonistsGREEN CROSS CORP·Filed 2006·Application pending·0 cites
- 3045US7507726B2Peptide deformylase inhibitorsSMITHKLINEBEECHAM CORP·Filed 2004·Granted Mar 24, 2009·0 cites·13 claims
- 3145US7166624B2Peptide deformylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 23, 2007·0 cites·8 claims
- 3243US12304905B2Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof1ST BIOTHERAPEUTICS INC·Filed 2020·Granted May 20, 2025·0 cites·10 claims
- 3343US7375120B2Peptide deformylase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted May 20, 2008·0 cites·4 claims
- 3441US9006187B2Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising sameLEE JINHWA·Filed 2011·Granted Apr 14, 2015·0 cites·16 claims
- 3538US8785453B2Arylpiperazine-containing purine derivatives and uses thereofLEE JINHWA·Filed 2010·Granted Jul 22, 2014·0 cites·6 claims
- 3633US2013217672A1(+)-3-hydroxymorphinan-based polycycle derivativesLEE JINHWA·Filed 2011·Application pending·0 cites
- 3732US2012122848A1(+)-3-hydroxymorphinan derivatives as neuroprotectantsLEE JINHWA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jinhwa Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →